Health and Healthcare
5865 Articles
Oddly, perhaps, the best performing stock in the first two weeks of the year is drug maker Merck.
The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the…
The the attacks against drug pricing and competition do not seem to be going away, but somehow, Merck has managed…
Obamacare repeal would add $7 million to the annual income of America's 400 richest taxpayers.
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a…
As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what…
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the…
Considering the new Trump administration, there is an increasingly positive sentiment in the health care sector. In the past year,…
Valeant Pharmaceuticals made waves early on Tuesday after the company offered announcements of a late-stage psoriasis trial and the sale…
Needless to say, the past two years have been rough on biotech. The question for investors is which of the…
Mergers and acquisitions are a way for companies to come together and complement each other’s business models. However, one acquisition…
As the second week of the New Year is now underway, a few biotech companies made sizable runs to kick…
Theranos's woes are a nearly perfect storm of loss of faith in its products, loss of faith in management, soured…
2017 could be different for the health care sector. It is very possible that this new administration could lead to…
Some biopharma companies can see a massive upside just from winning a single mid-stage trial or even achieving as much…
Our top personal finance-related articles today. Your wallet will thank you later.